1. Discovery of tert-amine-based RORγt agonists.
- Author
-
Qiu R, Yu M, Gong J, Tian J, Huang Y, Wang Y, and Xie Q
- Subjects
- Amines chemical synthesis, Amines chemistry, Animals, CD4-Positive T-Lymphocytes drug effects, Cell Differentiation drug effects, Cell Line, Dose-Response Relationship, Drug, Humans, Mice, Molecular Docking Simulation, Molecular Structure, Structure-Activity Relationship, Amines pharmacology, Drug Discovery, Nuclear Receptor Subfamily 1, Group F, Member 3 agonists
- Abstract
The nuclear receptor retinoic acid receptor-related orphan receptor gamma-t (RORγt) is a transcription factor regulating Th17 cell differentiation and proliferation from naive CD4
+ T cells. Since Th17 cells have demonstrated the antitumor efficacy by eliciting remarkable activation of CD8+ T cells, RORγt agonists could be applied as potential small molecule therapeutics for cancer immunotherapy. Based on the previously reported RORγt agonist 1 and its resolved co-crystal structure, a series of new tertiary amines were designed, synthesized and biologically evaluated, yielding optimal moieties with improved chemical properties and biological responses. The combination of these optimal moieties resulted in identification of novel RORγt agonists such as 8b with further elevated RORγt agonism responses at a target-based level as well as in cell-based assays, which provided some structural knowledge for further optimization of RORγt agonists as small molecule therapeutics for cancer immunotherapy., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2021 Elsevier Masson SAS. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF